PMC:7445716 / 67563-67756 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T573","span":{"begin":22,"end":33},"obj":"Body_part"},{"id":"T574","span":{"begin":22,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A573","pred":"fma_id","subj":"T573","obj":"http://purl.org/sig/ont/fma/fma5981"},{"id":"A574","pred":"fma_id","subj":"T574","obj":"http://purl.org/sig/ont/fma/fma65132"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T220","span":{"begin":22,"end":33},"obj":"Body_part"},{"id":"T221","span":{"begin":22,"end":27},"obj":"Body_part"}],"attributes":[{"id":"A220","pred":"uberon_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/UBERON_0002211"},{"id":"A221","pred":"uberon_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T601","span":{"begin":152,"end":154},"obj":"Disease"},{"id":"T602","span":{"begin":183,"end":193},"obj":"Disease"}],"attributes":[{"id":"A601","pred":"mondo_id","subj":"T601","obj":"http://purl.obolibrary.org/obo/MONDO_0007886"},{"id":"A602","pred":"mondo_id","subj":"T602","obj":"http://purl.obolibrary.org/obo/MONDO_0003757"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T597","span":{"begin":22,"end":27},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T278","span":{"begin":108,"end":119},"obj":"Chemical"},{"id":"T98491","span":{"begin":180,"end":182},"obj":"Chemical"}],"attributes":[{"id":"A55555","pred":"chebi_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/CHEBI_46195"},{"id":"A83616","pred":"chebi_id","subj":"T98491","obj":"http://purl.obolibrary.org/obo/CHEBI_73531"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"973","span":{"begin":151,"end":162},"obj":"Disease"},{"id":"974","span":{"begin":164,"end":173},"obj":"Disease"}],"attributes":[{"id":"A973","pred":"tao:has_database_id","subj":"973","obj":"MESH:D007889"},{"id":"A974","pred":"tao:has_database_id","subj":"974","obj":"MESH:D003680"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T408","span":{"begin":0,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T749","span":{"begin":165,"end":174},"obj":"Phenotype"},{"id":"T750","span":{"begin":183,"end":193},"obj":"Phenotype"}],"attributes":[{"id":"A749","pred":"hp_id","subj":"T749","obj":"http://purl.obolibrary.org/obo/HP_0002015"},{"id":"A750","pred":"hp_id","subj":"T750","obj":"http://purl.obolibrary.org/obo/HP_0010550"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T897","span":{"begin":22,"end":27},"obj":"UBERON:0001021"},{"id":"T898","span":{"begin":152,"end":154},"obj":"UBERON:0001088"}],"text":"Enhancement of caudal nerve roots IVIG 400 mg/kg (2 cycles) + temporary mechanical non-invasive ventilation Paracetamol At week 4 persistence of severe UL weakness, dysphagia, and LL paraplegia"}